Dina M Tawfik Caroline Dereux Jan-Alexis Tremblay Andre Boibieux Fabienne Braye Jean-Baptiste Cazauran Meja Rabodonirina Elisabeth Cerrato Audrey Guichard Fabienne Venet Guillaume Monneret Didier Payen Anne-Claire Lukaszewicz Julien Textoris
10.3389/fimmu.2022.883638
Front Immunol
2022 Aug 22;13:883638.
mucormycosis biomarkers immunotherapy interferon gamma adjunct therapy severe burn injuries
CC BY
https://pubmed.ncbi.nlm.nih.gov/36072605/
Burns / complications Mucormycosis / diagnosis Mucormycosis / drug therapy Mucormycosis / etiology
Burns / complications Mucormycosis / diagnosis Mucormycosis / drug therapy Mucormycosis / etiology Case Reports Research Support, Non-U.S. Gov't Adult Combined Modality Therapy Female HLA-DR Antigens Humans Interferon-gamma / therapeutic use Recombinant Proteins HLA-DR Antigens Recombinant Proteins Interferon-gamma
PMC9442803
36072605
Interferon gamma as an immune modulating adjunct therapy for invasive mucormycosis after severe burn - A case report
2022